Human Embryonic Stem Cell Therapy for Aplastic Anemia

Overview

Journal Clin Case Rep

Date 2017 Jun 8

PMID 28588839

Citations 1

Authors

Geeta Shroff

Rakesh Gupta

Lalduhawmi Zadeng

Affiliations

Soon will be listed here.

Abstract

Human embryonic stem cell (hESC) therapy is the potential therapeutic option for the treatment of patients with aplastic anemia (AA). The study showed a remarkable improvement in the AA patient subsequent to hESC administration. No adverse events occurred in the patient. hESC therapy is safe and effective for AA patients.

Citing Articles

Human Embryonic Stem Cell Derived from Early Stage Fertilized Ovum: Non Immunogenic and Universal, Neuronal and Non-neuronal Cell Lines.

Shroff G, Srivastav A, Shroff R Int J Stem Cells. 2018; 11(1):105-110.

PMID: 29699383 PMC: 5984064. DOI: 10.15283/ijsc17064.

References

Shroff G, Gupta A, Barthakur J . Therapeutic potential of human embryonic stem cell transplantation in patients with cerebral palsy. J Transl Med. 2014; 12:318. PMC: 4297392. DOI: 10.1186/s12967-014-0318-7. View

Tian X, Kaufman D . Differentiation of embryonic stem cells towards hematopoietic cells: progress and pitfalls. Curr Opin Hematol. 2008; 15(4):312-8. DOI: 10.1097/MOH.0b013e328302f429. View

Srivastava A, Nedelcu E, Esmaeli-Azad B, Mishra R, Carrier E . Thrombopoietin enhances generation of CD34+ cells from human embryonic stem cells. Stem Cells. 2007; 25(6):1456-61. DOI: 10.1634/stemcells.2006-0701. View

Issaragrisil S, Chansung K, Kaufman D, Sirijirachai J, Thamprasit T, Young N . Aplastic anemia in rural Thailand: its association with grain farming and agricultural pesticide exposure. Aplastic Anemia Study Group. Am J Public Health. 1997; 87(9):1551-4. PMC: 1380989. DOI: 10.2105/ajph.87.9.1551. View

Frickhofen N, Kaltwasser J, Schrezenmeier H, Raghavachar A, Vogt H, Herrmann F . Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med. 1991; 324(19):1297-304. DOI: 10.1056/NEJM199105093241901. View

Bacigalupo A, Bruno B, Saracco P, Di Bona E, Locasciulli A, Locatelli F . Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on.... Blood. 2000; 95(6):1931-4. View

Kim H, Kim B, Kim D, Hyun M, Kim S, Bae S . Comparison between matched related and alternative donors of allogeneic hematopoietic stem cells transplanted into adult patients with acquired aplastic anemia: multivariate and propensity score-matched analysis. Biol Blood Marrow Transplant. 2011; 17(9):1289-98. DOI: 10.1016/j.bbmt.2010.12.715. View

Mary J, Baumelou E, Guiguet M . Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood. 1990; 75(8):1646-53. View

Hamerschlak N, Maluf E, Pasquini R, Eluf-Neto J, Moreira F, Biasi Cavalcanti A . Incidence of aplastic anemia and agranulocytosis in Latin America--the LATIN study. Sao Paulo Med J. 2005; 123(3):101-4. PMC: 11060383. DOI: 10.1590/s1516-31802005000300002. View

10.

. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Postgrad Med. 2002; 48(3):206-8. View

11.

Chadwick K, Wang L, Li L, Menendez P, Murdoch B, Rouleau A . Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood. 2003; 102(3):906-15. DOI: 10.1182/blood-2003-03-0832. View

12.

Frickhofen N, Rosenfeld S . Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine. Semin Hematol. 2000; 37(1):56-68. DOI: 10.1016/s0037-1963(00)90030-1. View

13.

Benitez-Aranda H, Velez-Ruelas M, Diaz-Cardenas S, Sanchez-Valle E, Xolotl-Castillo M, Duenas-Gonzalez M . Incidence of aplastic anemia in a defined subpopulation from Mexico City. Hematology. 2004; 7(4):229-32. DOI: 10.1080/1024533021000024085. View

14.

Maluf E, Hamerschlak N, Biasi Cavalcanti A, Junior A, Eluf-Neto J, Falcao R . Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study. Haematologica. 2009; 94(9):1220-6. PMC: 2738713. DOI: 10.3324/haematol.2008.002642. View

15.

Young N, Scheinberg P, Calado R . Aplastic anemia. Curr Opin Hematol. 2008; 15(3):162-8. PMC: 3410534. DOI: 10.1097/MOH.0b013e3282fa7470. View

16.

Kojima S . Aplastic anemia in the Orient. Int J Hematol. 2002; 76 Suppl 2:173-4. DOI: 10.1007/BF03165112. View

17.

Scheinberg P, Young N . How I treat acquired aplastic anemia. Blood. 2012; 120(6):1185-96. PMC: 3418715. DOI: 10.1182/blood-2011-12-274019. View

18.

Passweg J, Marsh J . Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation. Hematology Am Soc Hematol Educ Program. 2011; 2010:36-42. DOI: 10.1182/asheducation-2010.1.36. View

19.

Gupta V, Eapen M, Brazauskas R, Carreras J, Aljurf M, Gale R . Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors. Haematologica. 2010; 95(12):2119-25. PMC: 2995571. DOI: 10.3324/haematol.2010.026682. View